Opioid metallopeptide compositions and methods

Details Opioid metallopeptide compositions and methods Opioid metallopeptide compositions and methods

2005-12-27

2005-12-27

Jones, Dameron L. (Department: 1618)

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

C424S001110, C424S001650, C424S009100, C534S014000

Reexamination Certificate

active

06979436

ABSTRACT:
Metallopeptides and metallopeptide combinatorial libraries specific for opioids receptors are provided, for use in biological, pharmaceutical and related applications. The metallopeptides and combinatorial libraries are made of peptides, peptidomimetics and peptide-like constructs, in which the peptide, peptidomimetic or construct is conformationally fixed in a biologically active configuration specific for one or more opioid receptors on complexation of a metal ion-binding portion thereof with a metal ion.

REFERENCES:
patent: 5432018 (1995-07-01), Dower et al.
patent: 5443816 (1995-08-01), Zamora et al.
patent: 5610271 (1997-03-01), Dooley et al.
patent: 5663295 (1997-09-01), Moreau et al.
patent: 5665865 (1997-09-01), Lerner et al.
patent: 5668254 (1997-09-01), Deghenghi
patent: 5679548 (1997-10-01), Barbas et al.
patent: 5733881 (1998-03-01), Schiller
patent: 5770178 (1998-06-01), Itaya et al.
patent: 5811400 (1998-09-01), Schiller
patent: 5872097 (1999-02-01), Fholenhag et al.
patent: 5883293 (1999-03-01), Gilon et al.
patent: 5885958 (1999-03-01), Zadina et al.
patent: 5891418 (1999-04-01), Sharma
patent: 5919897 (1999-07-01), Dooley et al.
patent: 5965701 (1999-10-01), Junien et al.
patent: 6027711 (2000-02-01), Sharma
patent: 6028063 (2000-02-01), Kruse et al.
patent: 6048527 (2000-04-01), Granoff et al.
patent: 6057357 (2000-05-01), Horwell et al.
patent: 6150335 (2000-11-01), Schiller
patent: 6284769 (2001-09-01), Dunn et al.
patent: 6331285 (2001-12-01), Sharma
patent: 6337319 (2002-01-01), Wang
patent: 2001/0009899 (2001-07-01), Keri et al.
patent: 2001/0041746 (2001-11-01), Kyle et al.
patent: 2002/0012948 (2002-01-01), Sharma et al.
patent: WO 97/07130 (1997-02-01), None
patent: WO 98/56796 (1998-12-01), None
patent: WO 99/10016 (1999-03-01), None
patent: WO 99/59997 (1999-11-01), None
patent: WO 99/65932 (1999-12-01), None
patent: WO 00/08027 (2000-02-01), None
patent: WO 00/51539 (2000-09-01), None
Pogozheva, Irina D., et al., “Opioid Receptor Three Dimensional Structures for distance Geometry Caluclations with Hydrogen Bonding Constraints,” Biophysical Journal, vol. 75, Aug. 1998, pp. 612-634.
Hruby, V.J., et al., “Cyclic Enkephalin Analogues with Exceptional Potentcy and Selectivity for Opioid Receptors,” ed. 40, J. Med. Chem. 1997, pp. 3957-3962.
Fabris, D., et al., “Investigation of Zinc Chelation in Zinc-Finger Arrays by Electrospray Mass Spectrometry”,Inorganic Chemistry, vol. 38,(1999), 1322-1325.
Giblin, Michael F., et al., “Design and Characterization of ()-melanocortin Peptide Analogs Cyclized through Rhenium and Technetium Metal Coordination”,Proceedings of National Academy Science USA, vol. 95,(Oct. 1998), 12814-12818.
Shi, Yi-Qun , et al., “Conformationally Constrained Metallpeptide Template for Melanocortin-1 Receptor”,American Chemistry Society, 218th ACS National Meeting, Abstracts of Papers, Part 1, Abstract MEDI 257,(Aug. 22, 1999).

Affiliated with

Also associated with

Rating

Opioid metallopeptide compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Opioid metallopeptide compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Opioid metallopeptide compositions and methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3520583